Clinical profile, contemporary management and one-year mortality in patients with severe acute heart failure syndromes: The EFICA study (Q34565386)

3 August 2017

Clinical profile, contemporary management and one-year mortality in patients with severe acute heart failure syndromes: The EFICA study (English)

1 reference

Acute decompensated heart failure

3 August 2017

0 references

0 references

1 reference

Patrick Blin

8

0 references

François Alla

object named as

François Alla

6

0 references

Faiez Zannad

1

object named as

Faiez Zannad

1 reference

3 August 2017

2

Alexandre Mebazaa

1 reference

3 August 2017

4

Alain Cohen-Solal

1 reference

3 August 2017

Yves Juillière

3

1 reference

3 August 2017

Louis Guize

5

1 reference

3 August 2017

Pierre Rougé

7

1 reference

3 August 2017

Marie-Hélène Barlet

9

1 reference

3 August 2017

Laurence Paolozzi

10

1 reference

3 August 2017

Catherine Vincent

11

1 reference

3 August 2017

Michel Desnos

12

1 reference

3 August 2017

Kamran Samii

13

1 reference

3 August 2017

EFICA Investigators

14

1 reference

3 August 2017

3 March 2006

1 reference

European Journal of Heart Failure

3 August 2017

1 reference

3 August 2017

8

1 reference

3 August 2017

7

1 reference

3 August 2017

697-705

1 reference

The problem of decompensated heart failure: nomenclature, classification, and risk stratification

3 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.01.001

A national survey of heart failure in French hospitals. The Myocardiopathy and Heart Failure Working Group of the French Society of Cardiology, the National College of General Hospital Cardiologists and the French Geriatrics Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.01.001

Heart failure etiology and response to milrinone in decompensated heart failure: results from the OPTIME-CHF study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.01.001

Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.01.001

Hospitalization of patients with heart failure: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.01.001

Incidence, clinical and etiologic features, and outcomes of advanced chronic heart failure: the EPICAL study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.01.001

Hospital outcomes in patients presenting with congestive heart failure complicating acute myocardial infarction: a report from the Second National Registry of Myocardial Infarction (NRMI-2)

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.01.001

Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.01.001

Frequency, patient characteristics, and outcomes of mild-to-moderate heart failure complicating ST-segment elevation acute myocardial infarction: lessons from 4 international fibrinolytic therapy trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.01.001

Platelet glycoprotein IIb/IIIa blockade and outcome of cardiogenic shock complicating acute coronary syndromes without persistent ST-segment elevation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.01.001

Heart failure after myocardial infarction: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.01.001

Cardiogenic shock with non-ST-segment elevation myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded coronaries for Cardiogenic shocK?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.01.001

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.01.001

Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.01.001

Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.01.001

The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.01.001

LINCS: L-NAME (a NO synthase inhibitor) in the treatment of refractory cardiogenic shock: a prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.01.001

Hypertensive pulmonary oedema is due to diastolic dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.01.001

Relation between gender, etiology and survival in patients with symptomatic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.01.001

Efficacy and safety of recombinant human activated protein C for severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.01.001

Survival after the onset of congestive heart failure in Framingham Heart Study subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.01.001

Differential clinical prognostic classifications in dilated and ischemic adbanced heart failure: The EPICAL study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.01.001

Effects of BG9719 (CVT-124), an A1-adenosine receptor antagonist, and furosemide on glomerular filtration rate and natriuresis in patients with congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.01.001

Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.01.001

The effectiveness and relative effectiveness of intravenous inotropic drugs acting through the adrenergic pathway in patients with heart failure-a meta-regression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.01.001

Epidemiology and outcome of acute lung injury in European intensive care units

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.01.001

One-Year Survival Following Early Revascularization for Cardiogenic Shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.01.001

10.1016/J.EJHEART.2006.01.001

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference